Development and Validation of a Combined Ferroptosis and Immune Prognostic Classifier for Hepatocellular Carcinoma

Background Immunotherapy and sorafenib exert anti-tumor effects via ferroptosis, but reliable biomarkers for the individual treatment and prognosis prediction of hepatocellular carcinoma (HCC) based on the ferroptosis and immune status remain lacking. Methods Ferroptosis-related genes (FRGs) were id...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yang Liu, Xi Zhang, Junjun Zhang, Juan Tan, Jie Li, Zewen Song
Formato: Artigo
Lenguaje:inglés
Publicado: 2020
Acceso en línea:https://doi.org/10.3389/fcell.2020.596679
https://www.frontiersin.org/articles/10.3389/fcell.2020.596679/pdf
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!